Live from the NIH registry
Studies recruiting near Trenton right now
Top 25 of 2,335 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Hospital of the University of Pennsylvania (Adults only) — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Pierre Fabre Medicament
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Acute Leukemia, Acute Myeloid Leukemia
N/A
Interventional 50 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Children's Hospital of Philadelphia
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Lung Cancer, Nonsmall Cell
Phase 1, Phase 2
Interventional 28 participants sought
Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey (24.5 mi)
· Sponsor: Syndax Pharmaceuticals
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Nationwide Children's Hospital
Assessment of Geriatric Evaluations Impact on New AML Guidance
AML, Adult
N/A
Observational 100 participants sought
Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital — New Brunswick, New Jersey (24.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Summit Health — Voorhees Township, New Jersey (22.8 mi)
· Sponsor: Pacific Edge Limited
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
Phase 4
Interventional 60 participants sought
Research Site — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: AstraZeneca
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Penn Prevention — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Westat
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Penn Medicine: University of Pennsylvania Health System — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Eli Lilly and Company
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Astera Cancer Care — East Brunswick, New Jersey (23.1 mi)
· Sponsor: Immuneering Corporation
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: RAI Services Company
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Pennsylvania — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: University of Pennsylvania
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
N/A
Observational 400 participants sought
Cooper University Hospital — Camden, New Jersey (27.9 mi)
· Sponsor: Cooper Norcross Health
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
Thomas Jefferson University Hospital — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: City of Hope Medical Center
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
University of Pennsylvania, Penn Presbyterian Medical Center — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
The Childrens Hospital of Philadelphia Kohls GI Nutrition and Diagnostic Center — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Stroke, Cerebrovascular Accident
N/A
Interventional 150 participants sought
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute — Edison, New Jersey (27.5 mi)
· Sponsor: Hackensack Meridian Health
Adaptive Radiation for Abdominopelvic Metastases
Neoplasm - Soft Tissue Pelvis Malignant Secondary, Malignant Neoplasm of Stomach
Phase 1
Interventional 30 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Fox Chase Cancer Center
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Crohn Disease
N/A
Interventional 60 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: Seattle Children's Hospital
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (28.2 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute